Crédit Mutuel Innovation

Credit Mutuel Innovation is the venture and growth investment arm of Credit Mutuel Alliance Federale, one of France’s major mutual banking groups. The firm invests across stages from late seed through growth equity, with a generalist thesis spanning software, fintech, industrial technology, and increasingly digital health and healthtech. The capital base is institutional and patient, with the bank-affiliated structure allowing for longer holds and meaningful follow-on. For healthcare AI founders, Credit Mutuel Innovation is a credible potential lead or co-lead at Series A and later, with check sizes typically ranging from EUR 2M to EUR 15M depending on stage and round dynamics. The strongest fit is for European, particularly French, healthcare AI companies with demonstrated commercial traction, ideally with regulated revenue, clinical pilots, or paying enterprise customers in the European market. Founders building pre-revenue platforms or pre-clinical biotech should look to specialist seed investors first; founders who lack any European go-to-market plan will face difficult diligence questions about market relevance. The firm’s value-add is most credible around French and European customer development, banking and corporate channels through the parent group, and connection to local institutional capital for subsequent rounds. Entry path is through the firm’s website, where intake is structured, or through a warm referral from a portfolio CEO or a French ecosystem operator. Expect rigorous commercial diligence with emphasis on unit economics, regulatory pathway, and management depth, alongside standard tech and product review. Be prepared for slower decision timelines than U.S. venture norms, reflecting the institutional capital base.